Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Reexamination Certificate
2005-06-28
2005-06-28
Dodson, Shelley A. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
C424S400000, C424S438000, C424S441000, C424S442000, C424S464000, C424S484000, C424S489000
Reexamination Certificate
active
06911215
ABSTRACT:
The invention is a dietary supplement for animals, especially dogs, for treating arthritis and joint discomfort. A biscuit form of the supplement may be in the form of a conventional carrier composition of, for example, typical dog biscuit materials including cereal grains, vegetables or animal meat, fat and by-products. Typically, the biscuit contains about 89-97 weight percent (wt. %) of the conventional carrier composition. Optional vitamins and minerals may also be added to the carrier material, typically in about the 1-5 wt. % range. Importantly, the biscuit of the present invention contains about 3-7 wt. % of an arthritis-treating combination, namely, glucosamine sulfate, vitamin C and an array of intracellular ions namely potassium, sodium and iodine. The glucosamine component is present by weight at approximately the same level as the vitamin C, and at approximately 10 (ten) times the level of the sum of the above-named intracellular ions. The biscuit is formulated so that its composition is approximately:Glucosamine component, 5 mg to 5,000 mg;Vitamin C component, 5 mg to 3,000 mg;Potassium component, 50 mcg to 150 mg;Sodium component, 50 mcg to 150 mg; andIodine component, 25 mcg to 100 mg.The biscuit is dosed at approximately 10 mg glucosamine component per pound of body weight of the animal per day.
REFERENCES:
patent: 4680309 (1987-07-01), Maurer
patent: 4853373 (1989-08-01), Livingston
patent: 5310759 (1994-05-01), Bockman
patent: 5364845 (1994-11-01), Henderson
patent: 5399347 (1995-03-01), Trentham et al.
patent: 5529786 (1996-06-01), Moore
patent: 5587363 (1996-12-01), Henderson
patent: 5720955 (1998-02-01), Weiner et al.
patent: 5750144 (1998-05-01), Moore
patent: 5840715 (1998-11-01), Florio
patent: 5843445 (1998-12-01), Weiner et al.
patent: 5849323 (1998-12-01), Braswell et al.
patent: 5849336 (1998-12-01), Aoyagi et al.
patent: 6024960 (2000-02-01), Kharazmi et al.
patent: 6139872 (2000-10-01), Walsh
patent: 6255295 (2001-07-01), Henderson et al.
patent: 6271213 (2001-08-01), Henderson et al.
Vidal y Plana R.R., Bizzarri D., Rovati A.L., “Articular cartilage Pharmacology: 1. In Vitro Studies on Glucosamine and Non Steroidal Anti Inflammatory Drugs”, Pharmacological Research Communications, vol. 10, No. 6, 1978, pp. 557-569.
Kirkpatrick, CJ; Mohr, W; Haferkamp, O; “Influence of Zinc and Copper on Lapine Articular Chondrocytes in Monolayer Culture: Morphology, Proliferation and Proteoglycan Synthesis”, Exp Cell Biol, 1982: 50:2, pp. 108-114.
Sandy, JD; Adams, ME; Billingham, ME; Plaas, A; Muir, H; In Vivo and In Vitro Stimulation of Chondrocyte Biosynthetic Activity in Early Experimental Osteoarthritis:, Arthritis Rheum, 1984 Apr., 27:4, pp. 388-397.
Gray, ML; Pizzanelli, AM; Grodzinsky, AJ; Lee, RC; Mechanical and Physiochemical Determinants of the Chondrocyte Biosynthetic Response, J Otrthop Res, 1986, 6:6, pp. 777-792.
Schalkwijk, J; Joosten, LA; Van Den Berg, WB; Van Wyk, JJ; Van De Putte, LB; Insulin-Like Growth Factor Stimulation of Chrondocyte Proteoglycan Synthesis By Human Synovial Fluid;, Arthritis Rheum, 1989 Jan., 31:1, pp. 66-71.
Jones, DG; Smith, RL; Stimulation of Adult Chondrocyte Metabolism by a Thyroid-Derived Factor;, J. Orthop Res, 1990 Mar., 8:2, pp./ 227-233.
Verschure, PJ; Joosten, LA; Van Der Kraan, PM; Van Den Berg, WB; Responsiveness of Articular Cartilage from Normal and Inflamed Mouse Knee Joints to Various Growth Factors;, Ann Rheum Dis, 1994 Jul, 543:7, pp. 455-460.
Koolpe, M; Benton, HP; Calcium-Mobilizing purine receptors on the Surface of Mammalian Articular Chondrocytes:, J Orthop Res, 1997 Mar., 15:2, pp. 204-212.
Venezian, R; Shenker, BJ; Datar, S; Leboy, PS; “Modulation of Chondrocyte Proliferation by Ascorbic Acid and BMP-2”, J Cell Physiol, 1998 Mar.,174:3, pp. 331-341.
McCluggage, Dave, “Better Health Through Natural Methods”, Natural Pet Magazine, Mar./Apr. 1998, p 66-67.
Kendall, Roger V., Therapeutic Nutrition for the Cat, Dog, and Horse:, Complementary and Alternative Veterinary Medicine, Principles and Practices, 1998, p. 64-65.
Canine Hip Dysplasia: An Unpredictable Disorder;, Dog Watch, Dec. 1997, vol. 1, No. 10, p. 5-8.
Kerwin, S. et al., Roundtable on Canine Osteoarthritis, Soothing Those Sore Joints, Veterinary Forum, Oct. 1997, p. 54-61.
Anderson, M. et al., “Evaluation of Clinical Efficacy of an Oral Glucosamine—Chondroitin Sulfate Compound”, Survey of Veterinary Practices in the United States, 24thAnnual Conference Veterinary Orthopedic Society, Mar. 1997, p. 1.
Koopman, William J., “Etiopathogenesis of Osteoarthritis”, Arthritis and Allied Conditions, A Textbook of Rheumatology, 13thEdition, 1997, p. 1969-1984.
Hanson, Reid RL, “Oral Glycosaminoglycans in Treatment of Degenerative Joint Disease in Horses”, Equlne Practice, Nov.-Dec. 1996, vol. 18, No. 10, p. 18-22.
Anderson, Mark et al., “Glycosaminoglycans in the Treatment of Degenerative Joint Disease in Small Animals”, Emerging Science & Technology, Summer 1996, p. 38 & 40.
Boothe, D. et al., “Roundtable Discussion—Degenerative Joint Disease in Dogs, Part 4”, Canine Practice, Jul.-Aug. 1996, vol. 21, No. 4, p. 19-23.
Boothe, D. et al., “Roundtable Discussion—Degenerative Joint Disease in Dogs, Part 3”, Canine Practice, May-Jun. 1996, vol. 21 , No. 3, p. 21-24.
Boothe, D. et al., “Roundtable Discussion—Degenerative Joint Disease in Dogs, Part 2”, Canine Practice, Mar.-Apr. 1996, vol. 21 , No. 2, p. 20-25.
Boothe, D. et al., “Roundtable Discussion—Degenerative Joint Disease in Dogs, Part 1”, Canine Practice, Jan.-Feb. 1996, vol. 21 , No. 1, p. 6-10.
Budavari, Susan, Description of Chondroitin Sulfate, The Merck Index—An Encyclopedia of Chemicals Drugs, and Biologicals, 12thEdition, 1996, p. 371.
Budavari, Susan, Description of Glucosamine, The Merck Index—An Enclycopedia of Chemicals Drugs, and Biologicals, 12thEdition, 1996, p. 758.
Bucci, Luke, Glycosaminoglycans, Nutrition Applied to Injury Rehabilitation and Sports Medicine, 1995, p. 177-203.
Muller-Fabbender, H. et al., Glucosamine Sulfate Compared to Ibuprofen in Osteoarthritis of the Knee, Osteoarthritis and Cartilage, vol. 2, No. 1, Mar. 1994, p. 61-69.
Fichard, A. et al., Another Look at Collagen V and XI Molecules:, Matrix Biology, vol. 14, 1994, p. 515-531.
Diab, Mohammad, The Role of Type IX Collagen in Osteoarthritis and Rheumatoid Arthritis:, Orthopaedic Review, vol. 12, No. 2, Feb. 1993, p. 165-170.
Clark, David M., The Biochemistry of Degenerative Joint Disease and Its Treatment:, Compendium on Continuing Education for the Practicing Veterinarian, vol. 13 (2), Feb. 1991, p. 275-281.
Setnikar, I. et al., Pharmacokinetics of Glucosamine in the Dog and in Man, Ameimittel-Forschung/Drug Research, Apr. 1986, p. 729-735.
Palmoski, Marshall et al., Effects of Some Nonsteroidal Anti-imflammatory Drugs on Proteoglycan Metabolism and Organization in Canine Articular Cartilage:, Arthritis and Rheumatism, vol. 23, No. 9, Sept. 1980, p. 1010-1020.
Drovanti, A. et al., Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthrosis: A Placebo-Controlled Double-Blind Investigation:, Clinical Therapeutics, vol. 3, No. 4, 1980, p. 260-272.
“Oral Chondroprotective Agents. Part I. Common Compounds”, Anderson, Mark A., Compend Contin Educ Pract Vet 21[7]:601-609 Jul.'99 Review Article 67 Refs.
“Oral Treatment with a Glucosamine-Chondroitin Sulfate Compound for Degenerative Joint Disease in Horses:25 Cases”, Hanson RR; Smalley, LR; Huff, GK; White S; Hammad TA, Equine Pract 19[9]:16-22 Oct.'97 Clinical Study 58 Refs.
Armstrong Teasdale LLP
Dodson Shelley A.
Nutri-Vet, LLC
LandOfFree
Treating arthritis in animals with dietary supplements does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating arthritis in animals with dietary supplements, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating arthritis in animals with dietary supplements will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522837